JW (Cayman) Therapeutics Co. Ltd (2126.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 937.38M |
| Enterprise Value | 696.77M |
| P/E Ratio | -1.05 |
| PEG Ratio | -0.16 |
| Price/Sales Ratio | 2.06 |
| Price/Book Ratio | 1.04 |
| Enterprise/Revenue | 1.2 |
| Enterprise/EBITDA | -1.54 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -1.96 |
| Operating Margin | -1.05 |
AD
Management Effectiveness
| Return On Assets | -0.56 |
| Return On Equity | -0.75 |
Income Statement
| Revenue | 276.31M |
| Revenue/Share | 0.67 |
| Gross Profit | 118.91M |
| EBITDA | -161.95M |
| Net Income | -540.92M |
| Diluted EPS | -1.3 |
Balance Sheet
| Total Cash | 503.28M |
| Total Cash/Share | 1.21 |
| Total Debt | 262.67M |
| Total Debt/Equity | 0.47 |
| Current Ratio | 1.45 |
| Book Value Per Share | 1.34 |
Price History
| 52-Week Change | -68.18 |
| 52-Week High | 6.35 |
| 52-Week Low | 1.4 |
| Moving Average 50 Days | 1.75 |
| Moving Average 200 Days | 2.42 |
Statistics
| Average Volume | 754,993 |
| Shares Outstanding | 416.47M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
